Kuk Hyoun Hwang serves as Executive at Bellevue Life Sciences Acquisition Corp., where they oversee executive responsibilities. Since joining the company, Kuk Hyoun Hwang has executed 11 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 23, 2023 involved transacting 20,000 shares valued at $0.
Kuk Hyoun Hwang currently holds 2,000,500 shares of Bellevue Life Sciences Acquisition Corp. (BLAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kuk Hyoun Hwang has been a net neutral trader of BLAC stock. They have purchased $0 and sold $0 worth of shares.
Kuk Hyoun Hwang's most recent insider trade was on Mar 23, 2023, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 21, 2023 | BLAC | $0 | Other | 225,000 | $N/A | Discretionary |
| Feb 14, 2023 | BLAC | $0 | Other | 30,000 | $N/A | Discretionary |
| Feb 14, 2023 | BLAC | $0 | Other | 225,000 | $N/A | Discretionary |
| Feb 14, 2023 | BLAC | $0 | Other | 20,000 | $N/A | Discretionary |
| Feb 14, 2023 | BLAC | $4.3M | Award | 430,000 | $10.00 | Discretionary |
| Feb 14, 2023 | BLAC | $0 | Other | 20,000 | $N/A | Discretionary |
| Feb 14, 2023 | BLAC | $0 | Other | 20,000 | $N/A | Discretionary |
| Feb 14, 2023 | BLAC | $0 | Other | 20,000 | $N/A | Discretionary |
| Feb 14, 2023 | BLAC | $0 | Other | 20,000 | $N/A | Discretionary |